p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone

MLA

Felix A. de la Iglesia, et al. “P53 Is Not Inactivated in B6C3F1 Mouse Vascular Tumors Arising Spontaneously or Associated with Long-Term Administration of the Thiazolidinedione Troglitazone.” Toxicology and Applied Pharmacology, vol. 156, no. 2, Apr. 1999. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....22430a825f5a935575cb6fcb6367c3d6&authtype=sso&custid=ns315887.

APA

Felix A. de la Iglesia, Susanne Gorospe, Steven K. Duddy, Robert F. Parker, Alexander W. Gough, Michael R. Bleavins, Paul E. Rowse, & L. A. Dethloff. (1999). p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone. Toxicology and Applied Pharmacology, 156(2).

Chicago

Felix A. de la Iglesia, Susanne Gorospe, Steven K. Duddy, Robert F. Parker, Alexander W. Gough, Michael R. Bleavins, Paul E. Rowse, and L. A. Dethloff. 1999. “P53 Is Not Inactivated in B6C3F1 Mouse Vascular Tumors Arising Spontaneously or Associated with Long-Term Administration of the Thiazolidinedione Troglitazone.” Toxicology and Applied Pharmacology 156 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....22430a825f5a935575cb6fcb6367c3d6&authtype=sso&custid=ns315887.